Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
Luca Richeldi, Leonardo M. Fabbri(University of Ferrara), Mario Luppi(University of Modena and Reggio Emilia), Barbara Meccugni(Policlinico di Modena), Roberto D’Amico(University of Modena and Reggio Emilia), Valentina Paci(University of Modena and Reggio Emilia), Fabio Rumpianesi(Policlinico di Modena), Angela Ferrari(University of Modena and Reggio Emilia), Irene Latorre(University of Modena and Reggio Emilia), Giovanni Ferrara(University of Modena and Reggio Emilia), Francesca Prati(University of Modena and Reggio Emilia), Stefania Cocchi(University of Modena and Reggio Emilia), Pietro Roversi(University of Leicester), Monica Losi(University of Modena and Reggio Emilia), Stefania Cerri(University of Modena and Reggio Emilia), Fabrizio Luppi(University of Modena and Reggio Emilia), Marisa Meacci(Policlinico di Modena), Cristina Mussini(University of Modena and Reggio Emilia), Roberto Esposito(University of Modena and Reggio Emilia), Mauro Codeluppi(University of Modena and Reggio Emilia), Giuseppe Torelli, Giorgio Enrico Gerunda(University of Modena and Reggio Emilia)
Cited by 157
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k